CN100376288C - T细胞介导的免疫的改善 - Google Patents

T细胞介导的免疫的改善 Download PDF

Info

Publication number
CN100376288C
CN100376288C CNB008089663A CN00808966A CN100376288C CN 100376288 C CN100376288 C CN 100376288C CN B008089663 A CNB008089663 A CN B008089663A CN 00808966 A CN00808966 A CN 00808966A CN 100376288 C CN100376288 C CN 100376288C
Authority
CN
China
Prior art keywords
cell
purposes
patient
thymus
castrating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB008089663A
Other languages
English (en)
Chinese (zh)
Other versions
CN1364093A (zh
Inventor
理查德·伦诺克斯·博伊德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norwood Immunology Ltd
Original Assignee
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monash University filed Critical Monash University
Publication of CN1364093A publication Critical patent/CN1364093A/zh
Application granted granted Critical
Publication of CN100376288C publication Critical patent/CN100376288C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB008089663A 1999-04-15 2000-04-17 T细胞介导的免疫的改善 Expired - Fee Related CN100376288C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP9778A AUPP977899A0 (en) 1999-04-15 1999-04-15 Improvement of t cell mediated immunity
AUPP9778 1999-04-15

Publications (2)

Publication Number Publication Date
CN1364093A CN1364093A (zh) 2002-08-14
CN100376288C true CN100376288C (zh) 2008-03-26

Family

ID=3813977

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB008089663A Expired - Fee Related CN100376288C (zh) 1999-04-15 2000-04-17 T细胞介导的免疫的改善

Country Status (11)

Country Link
EP (1) EP1191975A4 (fr)
JP (1) JP2002542174A (fr)
KR (1) KR20020007371A (fr)
CN (1) CN100376288C (fr)
AU (2) AUPP977899A0 (fr)
BR (1) BR0009712A (fr)
CA (1) CA2370296A1 (fr)
HK (1) HK1046249A1 (fr)
NZ (1) NZ514975A (fr)
WO (1) WO2000062657A2 (fr)
ZA (1) ZA200108451B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086000A1 (en) * 1999-04-15 2002-07-04 Richard Boyd Stimulation of thymus for vaccination development
US20020071829A1 (en) * 1999-04-15 2002-06-13 Richard Boyd Normalization of defective T cell responsiveness through manipulation of thymic regeneration
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
AU2002225245C1 (en) * 2000-10-13 2008-07-17 Norwood Immunology Ltd Improvement of graft acceptance through manipulation of thymic regeneration
AU2001295270B2 (en) * 2000-10-13 2007-08-09 Norwood Immunology Ltd Treatment of T cell disorders
EP1365790A4 (fr) * 2000-10-13 2006-05-31 Univ Monash Indicateur de diagnostic de la fonction thymique
AU2002216323C1 (en) * 2000-10-13 2008-05-29 Norwood Immunology Ltd Disease prevention by reactivation of the thymus
JP2004510795A (ja) * 2000-10-13 2004-04-08 モナッシュ・ユニバーシティ 胸腺の再生を操作することによる移植片受容の改善
AP2003002796A0 (en) * 2000-10-13 2003-06-30 Richard Boyd Disease prevention by reactivation of the thymus
CA2462073A1 (fr) * 2000-10-13 2002-04-18 Monash University Therapie genique aux cellules souches hematopoietiques
AU2002216320C1 (en) * 2000-10-13 2008-04-03 Norwood Immunology Ltd Hematopoietic stem cell gene therapy
IL147138A0 (en) * 2001-12-17 2002-08-14 Yeda Res & Dev Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation
KR20060022232A (ko) * 2003-04-18 2006-03-09 노르우드 이뮤놀러지 리미티드 흉선 재활성화 이전에 수행되는 질병 예방법 및 면역방법
EP2187953A2 (fr) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Utilisation d'un peptide en tant qu'agent thérapeutique
US9910039B2 (en) * 2011-07-01 2018-03-06 Beckman Coulter, Inc. Regulatory T cells and methods of identifying, obtaining and using to treat immuno-based disorders
CN103235135B (zh) * 2013-04-26 2015-02-04 史其新 一种用于表征外周调节性t细胞抑制活性的特征细胞群的检测方法及其应用
CN110691600B (zh) * 2016-11-11 2024-04-16 美商生命科学有限公司 使用人类间充质干细胞以实现细胞免疫及体液免疫的方法
US11819520B2 (en) 2018-02-23 2023-11-21 Duke University Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
KR20210005543A (ko) * 2018-02-23 2021-01-14 듀크 유니버시티 동종이계 고형 장기 이식물에 대한 공여자-특이적 내성을 증진시키는 배양된 융선 조직 이식

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001176A1 (fr) * 1986-08-18 1988-02-25 Bunge (Australia) Pty. Ltd. Regulation de la reproduction animale
WO1992019746A1 (fr) * 1991-04-29 1992-11-12 Csl Limited Vaccin de castration immunologique recombine et polypeptides destines a cet usage

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001176A1 (fr) * 1986-08-18 1988-02-25 Bunge (Australia) Pty. Ltd. Regulation de la reproduction animale
WO1992019746A1 (fr) * 1991-04-29 1992-11-12 Csl Limited Vaccin de castration immunologique recombine et polypeptides destines a cet usage

Also Published As

Publication number Publication date
EP1191975A2 (fr) 2002-04-03
ZA200108451B (en) 2003-01-15
AU779067B2 (en) 2005-01-06
EP1191975A4 (fr) 2005-05-25
JP2002542174A (ja) 2002-12-10
BR0009712A (pt) 2002-04-30
CN1364093A (zh) 2002-08-14
HK1046249A1 (zh) 2003-01-03
WO2000062657A3 (fr) 2001-01-11
NZ514975A (en) 2004-03-26
WO2000062657A2 (fr) 2000-10-26
KR20020007371A (ko) 2002-01-26
AUPP977899A0 (en) 1999-05-13
CA2370296A1 (fr) 2000-10-26
AU3797700A (en) 2000-11-02

Similar Documents

Publication Publication Date Title
CN100376288C (zh) T细胞介导的免疫的改善
US20060188521A1 (en) Treatment of T cell disorders
Matthiesen et al. Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy
Sugihara et al. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. III. Analysis of regulatory cells suppressing the induction of thyroiditis
US20040258672A1 (en) Graft acceptance through manipulation of thymic regeneration
US20060229251A1 (en) Treatment of T cell disorders
US20020136704A1 (en) Diagnostic indicator of thymic function
AU2001295270B2 (en) Treatment of T cell disorders
US20020119128A1 (en) Graft acceptance through manipulation of thymic regeneration
AU2001295270A1 (en) Treatment of T cell disorders
US20070274946A1 (en) Tolerance to Graft Prior to Thymic Reactivation
AU2002225245C1 (en) Improvement of graft acceptance through manipulation of thymic regeneration
US20020086003A1 (en) Stimulation of thymus for vaccination development
ZA200509363B (en) Tolerance to graft prior to thymic regeneration
WO2002030320A2 (fr) Stimulation du thymus pour ameliorer une vaccination
ZA200303684B (en) Stimulation of thymus for vaccination development
AU2007202609A1 (en) Stimulation of thymus for vaccination development

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: NORWOOD IMMUNOLOGY LTD.

Free format text: FORMER OWNER: MONASH UNIV.

Effective date: 20080314

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20080314

Address after: Vitoria Australia

Patentee after: Norwood Immunology Ltd.

Address before: Vitoria Australia

Patentee before: Monash Univ.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080326

Termination date: 20180417

CF01 Termination of patent right due to non-payment of annual fee